These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 35657616)

  • 1. Guidelines on models of diabetic heart disease.
    Heather LC; Hafstad AD; Halade GV; Harmancey R; Mellor KM; Mishra PK; Mulvihill EE; Nabben M; Nakamura M; Rider OJ; Ruiz M; Wende AR; Ussher JR
    Am J Physiol Heart Circ Physiol; 2022 Jul; 323(1):H176-H200. PubMed ID: 35657616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes and Heart Failure: A Marriage of Inconvenience.
    Mehta A; Bhattacharya S; Estep J; Faiman C
    Clin Geriatr Med; 2020 Aug; 36(3):447-455. PubMed ID: 32586474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetic Cardiomyopathy: Does the Type of Diabetes Matter?
    Hölscher ME; Bode C; Bugger H
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphological characteristics in diabetic cardiomyopathy associated with autophagy.
    Kanamori H; Naruse G; Yoshida A; Minatoguchi S; Watanabe T; Kawaguchi T; Tanaka T; Yamada Y; Takasugi H; Mikami A; Minatoguchi S; Miyazaki T; Okura H
    J Cardiol; 2021 Jan; 77(1):30-40. PubMed ID: 32907780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymptomatic Diabetic Cardiomyopathy: an Underrecognized Entity in Type 2 Diabetes.
    Stanton AM; Vaduganathan M; Chang LS; Turchin A; Januzzi JL; Aroda VR
    Curr Diab Rep; 2021 Sep; 21(10):41. PubMed ID: 34580767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms of diabetic cardiomyopathy.
    Bugger H; Abel ED
    Diabetologia; 2014 Apr; 57(4):660-71. PubMed ID: 24477973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart failure in diabetes.
    Jankauskas SS; Kansakar U; Varzideh F; Wilson S; Mone P; Lombardi A; Gambardella J; Santulli G
    Metabolism; 2021 Dec; 125():154910. PubMed ID: 34627874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current status on the therapeutic strategies for heart failure and diabetic cardiomyopathy.
    Kim AH; Jang JE; Han J
    Biomed Pharmacother; 2022 Jan; 145():112463. PubMed ID: 34839258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress in the treatment of diabetic cardiomyopathy, a systematic review.
    Shou Y; Li X; Fang Q; Xie A; Zhang Y; Fu X; Wang M; Gong W; Zhang X; Yang D
    Pharmacol Res Perspect; 2024 Apr; 12(2):e1177. PubMed ID: 38407563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What's new in heart failure in the patient with type 2 diabetes?
    Camafort M
    Endocrinol Nutr; 2015; 62(7):350-5. PubMed ID: 26228800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes and heart failure in the post-myocardial infarction patient.
    Estep JD; Aguilar D
    Curr Heart Fail Rep; 2006 Dec; 3(4):164-9. PubMed ID: 17129509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of heart failure development in type 2 diabetes: a practical approach.
    Verma S; Sharma A; Kanumilli N; Butler J
    Curr Opin Cardiol; 2019 Sep; 34(5):578-583. PubMed ID: 31219877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Average Clinician-Measured Blood Pressures and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Ischemic Heart Disease in the EXAMINE Trial.
    White WB; Jalil F; Cushman WC; Bakris GL; Bergenstal R; Heller SR; Liu Y; Mehta C; Zannad F; Cannon CP
    J Am Heart Assoc; 2018 Oct; 7(20):e009114. PubMed ID: 30371278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence.
    Tan Y; Zhang Z; Zheng C; Wintergerst KA; Keller BB; Cai L
    Nat Rev Cardiol; 2020 Sep; 17(9):585-607. PubMed ID: 32080423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycemic Control and the Heart: The Tale of Diabetic Cardiomyopathy Continues.
    Longo M; Scappaticcio L; Cirillo P; Maio A; Carotenuto R; Maiorino MI; Bellastella G; Esposito K
    Biomolecules; 2022 Feb; 12(2):. PubMed ID: 35204778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent diabetes and heart failure: interplay and novel therapeutic approaches.
    Karwi QG; Ho KL; Pherwani S; Ketema EB; Sun Q; Lopaschuk GD
    Cardiovasc Res; 2022 Feb; 118(3):686-715. PubMed ID: 33783483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Approach to Diabetic Cardiomyopathy: A Review of Human Studies.
    Tarquini R; Pala L; Brancati S; Vannini G; De Cosmo S; Mazzoccoli G; Rotella CM
    Curr Med Chem; 2018; 25(13):1510-1524. PubMed ID: 28685679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Navigating the "MACE" in Cardiovascular Outcomes Trials and decoding the relevance of Atherosclerotic Cardiovascular Disease benefits versus Heart Failure benefits.
    Hupfeld C; Mudaliar S
    Diabetes Obes Metab; 2019 Aug; 21(8):1780-1789. PubMed ID: 30957945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of Cardiovascular Disease in Diabetes.
    Haas AV; McDonnell ME
    Endocrinol Metab Clin North Am; 2018 Mar; 47(1):51-63. PubMed ID: 29407056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting mortality in people with type 2 diabetes mellitus after major complications: a study using Swedish National Diabetes Register data.
    Kelly PJ; Clarke PM; Hayes AJ; Gerdtham UG; Cederholm J; Nilsson P; Eliasson B; Gudbjornsdottir S
    Diabet Med; 2014 Aug; 31(8):954-62. PubMed ID: 24750341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.